Evotec and Immuneering to collaborate on AI driven ligand identification for rare hereditary metabolic diseases Read more
FDA Approves Gamifant (emapalumab-lzsg), the First and Only Treatment Indicated for Primary HLH Read more
GSK submits US regulatory filing to expand the use of Nucala in children with severe eosinophilic asthma Read more
Immunocore to co-develop IMC-C103C, a T cell redirecting bi-specific biologic, with Genentech Read more